STOCK TITAN

Elanco Animal Health Inc - ELAN STOCK NEWS

Welcome to our dedicated news page for Elanco Animal Health (Ticker: ELAN), a resource for investors and traders seeking the latest updates and insights on Elanco Animal Health.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Elanco Animal Health's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Elanco Animal Health's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.7%
Tags
none
-
Rhea-AI Summary
Elanco Animal Health to attend Goldman Sachs Global Healthcare Conference
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.19%
Tags
conferences
-
Rhea-AI Summary
Elanco Animal Health to attend Stifel 2023 Jaws and Paws Conference on June 1, 2023
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.9%
Tags
conferences
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.53%
Tags
-
Rhea-AI Summary
Elanco Animal Health has received conditional approval from the USDA for the first Canine Parvovirus Monoclonal Antibody, which is the first and only approved treatment for canine parvovirus. The treatment has shown targeted efficacy in treating the disease and can be administered to dogs eight weeks of age or older. Elanco expects to begin shipping the treatment in the coming weeks.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.52%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.52%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.3%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.18%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.98%
Tags
conferences
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.77%
Tags
conferences
Elanco Animal Health Inc

NYSE:ELAN

ELAN Rankings

ELAN Stock Data

7.07B
490.51M
0.65%
99.15%
2.53%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
US
Indianapolis

About ELAN

elanco is a global animal health company. our vision: food and companionship enriching life. elanco fulfills this vision through three primary pursuits: - helping deliver a safe, more affordable, more abundant food supply by improving the health and performance of animals - helping pets live longer, healthier, higher-quality lives - improving food safety elanco employees are empowered to preserve elanco’s common culture of humility, discipline and involvement. we have a responsibility to connect and contribute to our cause, to be passionate about delivering solutions and value to our customers, and to embrace opportunities for personal and professional growth and development. through innovative products, quality systems and a shared vision, elanco strives daily to enhance animal health—and enrich the lives of people worldwide.